Urinalysis Market Analysis By Product (Instruments, Consumables), By Application (Urinary Tract Infection, Diabetes, Kidney Diseases, Hypertension, Liver Diseases), By End-use (Hospitals, Clinical Laboratories, Home Healthcare, Research, and Academics) And Segment Forecasts To 2022

April 2016 | 89 pages | ID: UADD6BBF9E0EN
Grand View Research, Inc.

Abstracts

Global urinalysis market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable biochemical urine analyzers, automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is anticipated to foster the urinalysis market growth.

Contents

CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
1.4 Known, Unknown variables & target segment
Known, Unknown variables & target segment
1.5 Known variable derivation: Market size & dynamics
1.6 Unknown variable derivation: Market size & dynamics
Market derivation: Unknown variable
1.7 Company Market Share Analysis : Methodology

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 URINALYSIS INDUSTRY OUTLOOK

3.1 Market segmentation
3.2 Market size and growth prospects
3.3 Urinalysis : Market dynamics
  3.3.1 Market Driver Analysis
    3.3.1.1 Increasing prevalence of target diseases
    3.3.1.2 Introduction of technologically advanced diagnostics
    3.3.1.3 Growing base of geriatric population
    3.3.1.4 Introduction of CLIA waived tests
    3.3.1.5 Other drivers
  3.3.2 Market Restraint Analysis
    3.3.2.1 Lack of healthcare infrastructure
    3.3.2.2 Presence of ambiguous regulatory framework
3.4 Industry analysis Porter’s
3.5 Urinalysis : PESTEL Analysis
3.6 Urinalysis company market share/competitive landscape, 2014

CHAPTER 4 URINALYSIS PRODUCT OUTLOOK

4.1 Urinalysis market share by Product, 2014 & 2022
4.2 Instruments
  4.2.1 Instruments market, 2012 - 2022 (USD Million)
  4.2.2 Biochemical Urine Analyzer
    4.2.2.1 Biochemical urine analyzer market, 2012 - 2022 (USD Million)
    4.2.2.2 Automated Biochemical Analyzers
      4.2.2.2.1 Automated biochemical analyzer market, 2012 - 2022 (USD Million)
    4.2.2.3 Semi-automated Biochemical Analyzers
      4.2.2.3.1 Semi-automated biochemical analyzer market, 2012 - 2022 (USD Million)
  4.2.3 Automated Urine Sediment Analyzers
    4.2.3.1 Automated urine sediment analyzers market, 2012 - 2022 (USD Million)
    4.2.3.2 Microscopic urine analyzers
      4.2.3.2.1 Microscopic urine analyzers market, 2012 - 2022 (USD Million)
    4.2.3.3 Flow-cytometric urine analyzers
      4.2.3.3.1 Flow-cytometric urine analyzers market, 2012 - 2022 (USD Million)
4.3 Consumables
  4.3.1 Consumables market, 2012 - 2022 (USD Million)
  4.3.2 Dipsticks
    4.3.2.1 Dipsticks market, 2012 - 2022 (USD Million)
  4.3.3 Reagents
    4.3.3.1 Reagents market, 2012 - 2022 (USD Million)
  4.3.4 Disposables
    4.3.4.1 Disposables market, 2012 - 2022 (USD Million)

CHAPTER 5 URINALYSIS APPLICATION OUTLOOK

5.1 Urinalysis market share by application, 2014 & 2022
5.2 Urinary Tract Infections (UTI)
  5.2.1 Urinary tract infection (UTI) market, 2012 - 2022 (USD Million)
5.3 Diabetes
  5.3.1 Diabetes market, 2012 - 2022 (USD Million)
5.4 Kidney Diseases
  5.4.1 Kidney Diseases market, 2012 - 2022 (USD Million)
5.5 Hypertension
  5.5.1 Hypertension market, 2012 - 2022 (USD Million)
5.6 Liver Diseases
  5.6.1 Liver diseases market, 2012 - 2022 (USD Million)
5.7 Others
  5.7.1 Other applications market, 2012 - 2022 (USD Million)

CHAPTER 6 URINALYSIS END-USE OUTLOOK

6.1 Urinalysis market share by end-use, 2014 & 2022
6.2 Hospitals
  6.2.1 Hospitals market, 2012 - 2022 (USD Million)
6.3 Clinical Laboratories
  6.3.1 Clinical laboratories market, 2012 - 2022 (USD Million)
6.4 Home healthcare
  6.4.1 Home healthcare market, 2012 - 2022 (USD Million)
6.5 Research and Academics
  6.5.1 Research and academics market, 2012 - 2022 (USD Million)
6.6 Others
  6.6.1 Other end-uses market, 2012 - 2022 (USD Million)

CHAPTER 7 URINALYSIS REGIONAL OUTLOOK

7.1 Urinalysis Revenue Share by Region, 2014 & 2022
7.2 North America
  7.2.1 North America Urinalysis Market, 2012 - 2022 (USD Million)
  7.2.2 U.S.
    7.2.2.1 U.S. Urinalysis Market, 2012 - 2022 (USD Million)
  7.2.3 Canada
    7.2.3.1 Canada Urinalysis Market, 2012 - 2022 (USD Million)
7.3 Europe
  7.3.1 Europe Urinalysis Market, 2012 - 2022 (USD Million)
  7.3.2 UK
    7.3.2.1 UK Urinalysis Market, 2012 - 2022 (USD Million)
  7.3.3 Germany
    7.3.3.1 Germany Urinalysis Market, 2012 - 2022 (USD Million)
7.4 Asia Pacific
  7.4.1 Asia Pacific Urinalysis Market, 2012 - 2022 (USD Million)
  7.4.2 Japan
    7.4.2.1 Japan Urinalysis Market, 2012 - 2022 (USD Million)
  7.4.3 China
    7.4.3.1 China Urinalysis Market, 2012 - 2022 (USD Million)
7.5 Latin America
  7.5.1 Latin America Urinalysis Market, 2012 - 2022 (USD Million)
  7.5.2 Brazil
    7.5.2.1 Brazil Urinalysis Market, 2012 - 2022 (USD Million)
7.6 MEA
  7.6.2 South Africa
    7.6.2.1 South Africa Urinalysis Market, 2012 - 2022 (USD Million)

CHAPTER 8 COMPETITIVE LANDSCAPE

8.1 Alere Inc
  8.1.1 Company overview
  8.1.2 Financial performance
  8.1.3 Product Benchmarking
  8.1.4 Strategic Initiatives
8.2 Sysmex
  8.2.1 Company overview
  8.2.2 Financial performance
  8.2.3 Product Benchmarking
  8.2.4 Strategic Initiatives
8.3 ACON Laboratories, Inc
  8.3.1 Company overview
  8.3.2 Financial performance
  8.3.3 Product Benchmarking
  8.3.4 Strategic Initiatives
8.4 Bio-Rad
  8.4.1 Company overview
  8.4.2 Financial performance
  8.4.3 Product Benchmarking
  8.4.4 Strategic Initiatives
8.5 ARKRAY Inc
  8.5.1 Company overview
  8.5.2 Financial performance
  8.5.3 Product Benchmarking
  8.5.4 Strategic Initiatives
8.6 Roche Diagnostics
  8.6.1 Company overview
  8.6.2 Financial performance
  8.6.3 Product Benchmarking
  8.6.4 Strategic Initiatives
8.7 Mindray
  8.7.1 Company overview
  8.7.2 Financial performance
  8.7.3 Product Benchmarking
  8.7.4 Strategic Initiatives
8.8 Siemens Healthcare
  8.8.1 Company overview
  8.8.2 Financial performance
  8.8.3 Product Benchmarking
  8.8.4 Strategic Initiatives
8.9 Qidel Corporation
  8.9.1 Company overview
  8.9.2 Financial performance
  8.9.3 Product Benchmarking
  8.9.4 Strategic Initiatives